{"id":16131,"date":"2020-12-18T12:01:03","date_gmt":"2020-12-18T11:01:03","guid":{"rendered":"https:\/\/idibell.cat\/?p=16131"},"modified":"2020-12-18T12:01:19","modified_gmt":"2020-12-18T11:01:19","slug":"el-tractament-amb-ferro-redueix-el-risc-dhospitalitzacio-en-persones-amb-deficiencies-cardiaques","status":"publish","type":"post","link":"https:\/\/idibell.cat\/2020\/12\/el-tractament-amb-ferro-redueix-el-risc-dhospitalitzacio-en-persones-amb-deficiencies-cardiaques\/","title":{"rendered":"El tractament amb ferro redueix el risc d’hospitalitzaci\u00f3 en persones amb defici\u00e8ncies card\u00edaques"},"content":{"rendered":"

El Dr. Josep Com\u00edn, cap del grup de malalties cardiovasculars de l’IDIBELL i cap del servei de cardiologia de l’Hospital Universitari de Bellvitge (HUB), ha participat en l’estudi “AFFIRM-AHF”. Aquest estudi avalua l’efecte del tractament amb ferro carboximaltosa en les hospitalitzacions per insufici\u00e8ncia card\u00edaca i en la mortalitat cardiovascular en pacients amb d\u00e8ficit de ferro, despr\u00e9s de la seva estabilitzaci\u00f3 per ingr\u00e9s d’insufici\u00e8ncia card\u00edaca aguda.<\/p>\n

Els resultats, donats a con\u00e8ixer de forma simult\u00e0nia en el congr\u00e9s virtual de l’American Heart Association (AHA) 2020 i a la revista The Lancet<\/a>, mostren que els pacients que van rebre el suplement de ferro tenien un 26% menys de probabilitats de ser reingressats a l’hospital per insufici\u00e8ncia card\u00edaca respecte al grup control.<\/p>\n

L’estudi va comptar amb 1.108 pacients de 15 pa\u00efsos diferents que havien estat donats d’alta despr\u00e9s de ser hospitalitzats per una insufici\u00e8ncia card\u00edaca aguda i als quals se’ls va detectar nivells baixos de ferro en la seva estada a l’hospital. Els participants van ser dividits en dos grups, un va rebre el tractament amb ferro i l’altre va rebre placebo. Despr\u00e9s de 52 setmanes, aquells pacients que havien rebut el suplement de ferro mostraven menys probabilitats de tornar a ser ingressats a l’hospital.<\/p>\n

 <\/p>\n

 <\/p>\n

L\u2019Institut d’Investigaci\u00f3 Biom\u00e8dica de Bellvitge (IDIBELL) \u00e9s un centre de recerca en biomedicina creat l\u2019any 2004. Est\u00e0 participat per l’Hospital Universitari de Bellvitge i l\u2019Hospital de Viladecans de l’Institut Catal\u00e0 de la Salut, l’Institut Catal\u00e0 d’Oncologia, la Universitat de Barcelona i l\u2019Ajuntament de l\u2019Hospitalet de Llobregat.<\/em><\/p>\n

L\u2019IDIBELL \u00e9s membre del Campus d’Excel\u00b7l\u00e8ncia Internacional de la Universitat de Barcelona HUBc i forma part de la instituci\u00f3 CERCA de la Generalitat de Catalunya. L’any 2009 es va convertir en un dels cinc primers centres d\u2019investigaci\u00f3 espanyols acreditats com a institut d\u2019investigaci\u00f3 sanit\u00e0ria per l\u2019Instituto de Salud Carlos III. A m\u00e9s, forma part del programa \u201cHR Excellence in Research\u201d de la Uni\u00f3 Europea i \u00e9s membre de EATRIS i REGIC. Des de l\u2019any 2018, l\u2019IDIBELL \u00e9s un Centro Acreditado de la Fundaci\u00f3n Cient\u00edfica AECC (FCAECC).<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"

Els resultats, donats a con\u00e8ixer de forma simult\u00e0nia en el congr\u00e9s virtual de l’American Heart Association (AHA) 2020 i a la revista The Lancet, mostren que els pacients que van rebre el suplement de ferro tenien un 26% menys de probabilitats de ser reingressats a l’hospital per insufici\u00e8ncia card\u00edaca respecte al grup control<\/p>\n","protected":false},"author":8,"featured_media":16132,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"default","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[359,334,466],"tags":[],"class_list":["post-16131","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-malalties-cardiovasculars","category-medicina-translacional","category-p-de-malalties-cardiovasculars-respiratories-sistemiques-i-denvelliment-cellular"],"publishpress_future_action":{"enabled":false,"date":"2024-11-29 08:35:18","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category"},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/16131","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/comments?post=16131"}],"version-history":[{"count":0,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/16131\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media\/16132"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media?parent=16131"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/categories?post=16131"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/tags?post=16131"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}